NCT04553692 2025-03-28Phase 1a/1b Study of Aplitabart (IGM-8444) Alone or in Combination in Participants with Relapsed, Refractory, or Newly Diagnosed CancersIGM Biosciences, Inc.Phase 1 Terminated272 enrolled
NCT03435250 2024-07-25Study of AG-270 in Participants With Advanced Solid Tumors or Lymphoma With MTAP LossServierPhase 1 Terminated123 enrolled